DK0539522T3 - Forbedret immunterapeutisk fremgangsmåde til hindring eller behandling af viral sygdom i luftvejene - Google Patents

Forbedret immunterapeutisk fremgangsmåde til hindring eller behandling af viral sygdom i luftvejene

Info

Publication number
DK0539522T3
DK0539522T3 DK91915687T DK91915687T DK0539522T3 DK 0539522 T3 DK0539522 T3 DK 0539522T3 DK 91915687 T DK91915687 T DK 91915687T DK 91915687 T DK91915687 T DK 91915687T DK 0539522 T3 DK0539522 T3 DK 0539522T3
Authority
DK
Denmark
Prior art keywords
respiratory tract
prevention
treatment
viral disease
improved immunotherapeutic
Prior art date
Application number
DK91915687T
Other languages
Danish (da)
English (en)
Inventor
Robert Merritt Chanock
Gregory Antone Prince
Kathleen Louise Coelingh
Brian Robert Murphy
Val Hemming
Judy Allyson Beeler
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce filed Critical Us Commerce
Application granted granted Critical
Publication of DK0539522T3 publication Critical patent/DK0539522T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK91915687T 1990-07-19 1991-07-19 Forbedret immunterapeutisk fremgangsmåde til hindring eller behandling af viral sygdom i luftvejene DK0539522T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55509190A 1990-07-19 1990-07-19
PCT/US1991/005002 WO1992001473A1 (fr) 1990-07-19 1991-07-19 Procede immunotherapeutique ameliore pour la prevention ou le traitement des maladies virales des voies respiratoires

Publications (1)

Publication Number Publication Date
DK0539522T3 true DK0539522T3 (da) 1999-08-30

Family

ID=24215926

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91915687T DK0539522T3 (da) 1990-07-19 1991-07-19 Forbedret immunterapeutisk fremgangsmåde til hindring eller behandling af viral sygdom i luftvejene

Country Status (10)

Country Link
EP (1) EP0539522B1 (fr)
JP (1) JP2631767B2 (fr)
AT (1) ATE175123T1 (fr)
AU (1) AU644210B2 (fr)
CA (1) CA2087100A1 (fr)
DE (1) DE69130708T2 (fr)
DK (1) DK0539522T3 (fr)
ES (1) ES2129028T3 (fr)
GR (1) GR3029324T3 (fr)
WO (1) WO1992001473A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0530216A4 (en) * 1990-04-19 1993-06-30 Medimmune, Inc. Administration of monoclonal antibodies against respiratory viruses
GB9207479D0 (en) * 1992-04-06 1992-05-20 Scotgen Ltd Novel antibodies for treatment and prevention of respiratory syncytial virus infection in animals and man
DK0671927T3 (da) * 1992-09-16 2003-04-22 Us Gov Health & Human Serv Neutraliserende humane monoklonale antistoffer mod respiratorisk syncytialvirus
US6685942B1 (en) 1993-12-10 2004-02-03 The Scripps Research Institute Human neutralizing monoclonal antibodies to respiratory syncytial virus
EP0724602A4 (fr) * 1993-07-30 1998-12-23 Oravax Inc ANTICORPS IgA MONOCLONAL DIRIGE CONTRE LE VIRUS RESPIRATOIRE SYNCYTIAL
US5922344A (en) * 1995-02-10 1999-07-13 Abbott Laboratories Product for prevention of respiratory virus infection and method of use
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
ES2525087T5 (es) 2000-05-10 2018-06-28 Novartis Ag Polvos basados en fosfolípidos para administración de fármacos
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US20050271660A1 (en) * 2002-09-06 2005-12-08 Alexion Pharmaceuticals, Inc. Nebulization of monoclonal antibodies for treating pulmonary diseases
JP2009528828A (ja) * 2006-03-06 2009-08-13 シムフォゲン・アクティーゼルスカブ 消化器多核体ウイルス感染症の治療のための組み換えポリクローナル抗体
CA2678628A1 (fr) 2007-03-06 2008-09-12 Symphogen A/S Anticorps recombinants pour le traitement des infections au virus respiratoire syncytial
US10100102B2 (en) * 2012-10-29 2018-10-16 The University Of North Carolina At Chapel Hill Compositions and methods for inhibiting pathogen infection
US10829543B2 (en) 2012-10-29 2020-11-10 The University Of North Carolina At Chapel Hill Compositions and methods for inhibiting pathogen infection
RU2729546C2 (ru) 2014-04-03 2020-08-07 Цсл Беринг Аг Распыление иммуноглобулина
WO2017083681A1 (fr) 2015-11-13 2017-05-18 The University Or North Carolina At Chapel Hill Agents de réticulation optimisés pour piéger une cible sur un substrat
WO2019183228A1 (fr) * 2018-03-21 2019-09-26 The University Of North Carolina At Chapel Hill Compositions et procédés d'inhibition d'une infection pathogène

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2590674B1 (fr) * 1985-11-25 1989-03-03 Inst Nat Sante Rech Med Nouveaux reactifs de diagnostic
US4800078A (en) * 1987-05-28 1989-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
US4891221A (en) * 1988-11-23 1990-01-02 Edward Shanborm Whole blood antiviral process and composition
EP0530216A4 (en) * 1990-04-19 1993-06-30 Medimmune, Inc. Administration of monoclonal antibodies against respiratory viruses
GB9019812D0 (en) * 1990-09-11 1990-10-24 Scotgen Ltd Novel antibodies for treatment and prevention of infection in animals and man

Also Published As

Publication number Publication date
ES2129028T3 (es) 1999-06-01
GR3029324T3 (en) 1999-05-28
EP0539522A1 (fr) 1993-05-05
ATE175123T1 (de) 1999-01-15
WO1992001473A1 (fr) 1992-02-06
JP2631767B2 (ja) 1997-07-16
AU8403091A (en) 1992-02-18
EP0539522B1 (fr) 1998-12-30
DE69130708T2 (de) 1999-05-27
AU644210B2 (en) 1993-12-02
EP0539522A4 (en) 1993-09-08
DE69130708D1 (de) 1999-02-11
JPH06501928A (ja) 1994-03-03
CA2087100A1 (fr) 1992-01-20

Similar Documents

Publication Publication Date Title
DK0539522T3 (da) Forbedret immunterapeutisk fremgangsmåde til hindring eller behandling af viral sygdom i luftvejene
GEP20012429B (en) Urease-Based Vaccine Against Helicobacter Infection
DE69225471D1 (de) Abgeschwächtes, gentechnologisch hergestelltes pseudorabies virus s-prv-155 und seine verwendungen
DE69033487D1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
ATE17320T1 (de) Impfstoff, therapie gegen nicht-a nicht-b virale hepatitis und verfahren zur herstellung desselben.
GR3029774T3 (en) Method of preparing a radioactive rhenium complex solution.
SE8205313D0 (sv) Antigen-proteinkomplex for blockering av allergiska reaktioner samt sett for framstellning derav
DE69127487D1 (de) Verfahren zum Nachweis der Alzheimer-Krankheit
CA2108259A1 (fr) Methode d'analyse d'echantillons de plasma pour determiner efficacement le titre d'anticorps a appliquer contre les virus respiratoires
FI842215A (fi) Foerfarande foer framstaellning av levande effektiveringsvaccin och pao detta saett erhaollna vaccin.
KR100218138B1 (en) Methods and vaccines comprising surface-active copolymers
DE69034264D1 (de) Verfahren zur Herstellung eines azellulären Impfstoffes der Bordetella pertussis Antigene enthält
ES2165884T3 (es) Preparacion farmaceutica estable que no contiene actividad viral consistente en al menos un 70%, preferiblemente un 90% de inmunoglobulina a humana monomera, y procedimiento de preparacion.
SE9202968D0 (sv) New peptides, diagnostic antigens, use thereof, vaccines and medicaments
ATE285791T1 (de) Impfstoff, der acemannan als adjuvans enthält
EP0530216A4 (en) Administration of monoclonal antibodies against respiratory viruses
SE9201281D0 (sv) New human monoclonal antibodies, and a method for preparation thereof
WO1991010735A3 (fr) Recepteur humain de la tsh. sequence codant pour ce recepteur
JPS5615215A (en) Preparation of human immunoglobulin for intravenous injection with immobilized pepsin gel
DK0545951T3 (da) HRSV-vaccine
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
EP0512023A4 (en) Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens
NO923749D0 (no) Bcrf1-antagonister for behandling av epstein-barr-virusinfeksjoner
Corthier ANTIGENIC COMPARISON OF SWINE FEVER VIRUS (SFV.) AND MUCOSAL DISEASE VIRUS (MDV)